Tags

Type your tag names separated by a space and hit enter

[Genetics and present therapy options in Parkinson's disease: a review].
Ideggyogy Sz. 2009 May 30; 62(5-6):155-63.IS

Abstract

In the past years, six monogenic forms of Parkinson disease have clearly been associated with this movement disorder. The most frequent forms are LRRK2- and Parkin-associated Parkinson disease. Currently, a genetic diagnosis does not change the therapy, the genes involved in genetic Parkinson disease help to understand the underlying pathophysiologic mechanisms of Parkinson disease. Beside the overview of the molecular-genetic basis, we give a review about genetic testing, pharmacological and other multidisciplinary treatment options.

Authors+Show Affiliations

Semmelweis Egyetem, Molekuláris Neurológiai Klinikai és Kutatási Központ, Budapest. bereznaib@neur.sote.huNo affiliation info available

Pub Type(s)

Journal Article
Review

Language

hun

PubMed ID

19579663

Citation

Bereznai, Benjamin, and Mária Judit Molnar. "[Genetics and Present Therapy Options in Parkinson's Disease: a Review]." Ideggyogyaszati Szemle, vol. 62, no. 5-6, 2009, pp. 155-63.
Bereznai B, Molnar MJ. [Genetics and present therapy options in Parkinson's disease: a review]. Ideggyogy Sz. 2009;62(5-6):155-63.
Bereznai, B., & Molnar, M. J. (2009). [Genetics and present therapy options in Parkinson's disease: a review]. Ideggyogyaszati Szemle, 62(5-6), 155-63.
Bereznai B, Molnar MJ. [Genetics and Present Therapy Options in Parkinson's Disease: a Review]. Ideggyogy Sz. 2009 May 30;62(5-6):155-63. PubMed PMID: 19579663.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Genetics and present therapy options in Parkinson's disease: a review]. AU - Bereznai,Benjamin, AU - Molnar,Mária Judit, PY - 2009/7/8/entrez PY - 2009/7/8/pubmed PY - 2009/7/25/medline SP - 155 EP - 63 JF - Ideggyogyaszati szemle JO - Ideggyogy Sz VL - 62 IS - 5-6 N2 - In the past years, six monogenic forms of Parkinson disease have clearly been associated with this movement disorder. The most frequent forms are LRRK2- and Parkin-associated Parkinson disease. Currently, a genetic diagnosis does not change the therapy, the genes involved in genetic Parkinson disease help to understand the underlying pathophysiologic mechanisms of Parkinson disease. Beside the overview of the molecular-genetic basis, we give a review about genetic testing, pharmacological and other multidisciplinary treatment options. SN - 0019-1442 UR - https://www.unboundmedicine.com/medline/citation/19579663/[Genetics_and_present_therapy_options_in_Parkinson's_disease:_a_review]_ DB - PRIME DP - Unbound Medicine ER -